Alex L. Harris

1.6k total citations
35 papers, 1.2k citations indexed

About

Alex L. Harris is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Alex L. Harris has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Physiology and 7 papers in Cell Biology. Recurrent topics in Alex L. Harris's work include Nitric Oxide and Endothelin Effects (7 papers), Phosphodiesterase function and regulation (6 papers) and Calpain Protease Function and Regulation (5 papers). Alex L. Harris is often cited by papers focused on Nitric Oxide and Endothelin Effects (7 papers), Phosphodiesterase function and regulation (6 papers) and Calpain Protease Function and Regulation (5 papers). Alex L. Harris collaborates with scholars based in United States, United Kingdom and Brazil. Alex L. Harris's co-authors include Paul J. Silver, Ross Bentley, L T Hamel, Dale B. Evans, Edward D. Pagani, Jill S. Gregory, Roland E. Dolle, L A Sklar, Geneva M. Omann and Todd L. Graybill and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Alex L. Harris

33 papers receiving 1.1k citations

Peers

Countries citing papers authored by Alex L. Harris

Since Specialization

Citations

This map shows the geographic impact of Alex L. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex L. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex L. Harris more than expected).

Fields of papers citing papers by Alex L. Harris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex L. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex L. Harris. The network helps show where Alex L. Harris may publish in the future.

Co-authorship network of co-authors of Alex L. Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Alex L. Harris. A scholar is included among the top collaborators of Alex L. Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex L. Harris. Alex L. Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Still the Outsiders? Women in Sport Journalism 2025 ·International Journal of Sport Communication ·Alex L. Harris, Ali Bowes	0
2	Branching beyond bifunctional linkers: synthesis of macrocyclic and trivalent PROTACs 2025 ·Nature Protocols ·Yuting Cao, Alex L. Harris, Alessio Ciulli	0
3	CHIR-265 is a potent selective inhibitor of c-Raf/B-Raf/mutB-Raf that effectively inhibits proliferation and survival of cancer cell lines with Ras/Raf pathway mutations 2006 ·Cancer Research ·Payman Amiri, Mina Aikawa, (unknown), Darrin D. Stuart, Daniel Poon, (unknown), Savithri Ramurthy, Sharadha Subramanian, Barry H. Levine, Abran Costales, Alex L. Harris, (unknown)	18
4	I (Don't) Hate School: Revisiting Oppositional Culture Theory of Blacks' Resistance to Schooling 2006 ·Social Forces ·Alex L. Harris	96
5	Antibacterial Peptides in Bronchoalveolar Lavage Fluid 1998 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown), Alex L. Harris	45
6	Aspartyl .alpha.-((Diphenylphosphinyl)oxy)methyl Ketones as Novel Inhibitors of Interleukin-1.beta. Converting Enzyme. Utility of the Diphenylphosphinic Acid Leaving Group for the Inhibition of Cysteine Proteases 1995 ·Journal of Medicinal Chemistry ·Roland E. Dolle, J. B. Singh, David A. Whipple, (unknown), (unknown), Todd L. Graybill, Jill S. Gregory, Alex L. Harris, Carla T. Helaszek	25
7	Phevalin, a New Calpain Inhibitor, from a Streptomyces sp. 1995 ·The Journal of Antibiotics ·Maria E. Alvarez, (unknown), Jill S. Gregory, (unknown), Alex L. Harris, Hao Sun, Amanda M. Gillum, Raymond Cooper	34
8	Inhibition of human erythrocyte calpain I by novel quinolinecarboxamides 1995 ·Bioorganic & Medicinal Chemistry Letters ·Todd L. Graybill, Roland E. Dolle, (unknown), Stanley J. Schmidt, Jill S. Gregory, Alex L. Harris, Matthew S. Miller	14
9	5,7-Dimethoxy-3-(4-Pyridinyl)Quinoline Is a Potent and Selective Inhibitor of Human Vascular .beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine Kinase 1994 ·Journal of Medicinal Chemistry ·Roland E. Dolle, Joseph A. Dunn, Mark A. Bobko, Baldev Singh, Joan E. Kuster, Eugene R. Baizman, Alex L. Harris, David G. Sawutz, Deborah Miller, Su Wang, Connie R. Faltynek, (unknown), Jay Sarup, (unknown), Edward D. Pagani, Paul J. Silver	36
10	Developing a research and development strategy for primary care. 1993 ·BMJ ·Alex L. Harris	4
11	Vascular protein kinase C in Wistar-Kyoto and spontaneously hypertensive rats 1992 ·European Journal of Pharmacology ·Paul J. Silver, (unknown), Alex L. Harris	13
12	Inhibition of Low Km Cyclic GMP Phosphodiesterases and Potentiation of Guanylate Cyclase Activators by Cicletanine 1990 ·Journal of Cardiovascular Pharmacology ·Paul J. Silver, (unknown), Ronald L. Dundore, Alex L. Harris, Edward D. Pagani	22
13	Beneficial hemodynamic effects of milrinone and enalapril in conscious rats with healed myocardial infarction 1989 ·European Journal of Pharmacology ·Albert DeFelice, Alex L. Harris, (unknown), Patrick Horan	5
14	Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle. 1989 ·Journal of Pharmacology and Experimental Therapeutics ·Alex L. Harris, (unknown), Ross Bentley, Mark H. Perrone, L T Hamel, Paul J. Silver	48
15	Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig. 1989 ·Journal of Pharmacology and Experimental Therapeutics ·Alex L. Harris, Mary J. Connell, Edward Ferguson, Andrew Wallace, (unknown), Edward D. Pagani, Paul J. Silver	93
16	The vasorelaxant effects of milrinone and other vasodilators are attenuated by ouabain 1988 ·European Journal of Pharmacology ·Alex L. Harris, Paul J. Silver, (unknown), Dale B. Evans	7
17	Protein kinase C activity and reactivity to phorbol ester in vascular smooth muscle from spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto rats (WKY) 1988 ·Biochemical and Biophysical Research Communications ·Paul J. Silver, (unknown), (unknown), (unknown), Alex L. Harris	19
18	Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone. 1988 ·Journal of Pharmacology and Experimental Therapeutics ·Paul J. Silver, (unknown), Brendan O’Connor, (unknown), L T Hamel, Ross Bentley, Alex L. Harris	66
19	LTB4 induced activation signals and responses in neutrophils are short-lived compared to formylpeptide. 1987 ·The Journal of Immunology ·Geneva M. Omann, (unknown), Alex L. Harris, L A Sklar	60
20	Red blood cell sodium in the DOCA hypertensive pig. 1983 ·Hypertension ·(unknown), Alex L. Harris, Boony Thio, R. S. Moreland, David F. Bohr	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact